The AAV vector market is advancing due to the rising demand for gene therapies targeting disease causes at the cellular level ...

A single one-time gene therapy could free patients with α-thalassemia, a rare and debilitating blood disorder, from the ...

In a preclinical study, researchers applied an innovative treatment approach for genetic hearing loss and found that it ...

The cancer gene therapy market's growth is propelled by rising R&D investments, increasing cancer incidence, and supportive regulations. Key opportunities lie in advancements in immunotherapy and ...

The re-transcribed DNA is then integrated into the genome of the host cell (Figure 2). This process requires the absence of the nuclear membrane and thus is restricted to the M-phase of proliferating ...

DELRAY BEACH, FL / ACCESS Newswire / August 12, 2025 / Adolore BioTherapeutics, Inc., (“Company” or “Adolore”) announced that Roy Clifford Levitt, MD, Clinical Professor at the University of Miami, ...

Gene therapy involves the introduction of foreign genomic materials into host cells to trigger clinical benefits. 1 Over the years, scientists have developed numerous viral and non-viral vectors to ...

UCLA researchers have made strides in developing a stem cell gene therapy for alpha thalassemia major, a severe, inherited ...

DINAMIQS, a Siegfried company, has inaugurated Switzerland’s first cGMP manufacturing facility for viral vectors, enhancing its capabilities in the cell and gene therapy market. This facility, located ...

Jesse Gelsinger died after receiving a gene therapy treatment to treat a liver disease. The death sparked an investigation ...